Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
European Heart Journal - Cardiovascular Pharmacotherapy is Scopus-indexed (Q1, CiteScore 11), WoS SCIE. Published by Oxford University Press.
Checked against the index lists dated .
ISSN 2055-6837Verify ISSN ↗2055-6845Verify ISSN ↗
Publisher: Oxford University Press
Cost to publish: About US$4,501 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 18 / 278 | 93rd | Q1 |
| Cardiology and Cardiovascular Medicine | 30 / 409 | 92nd | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q1, CiteScore 11.
European Heart Journal - Cardiovascular Pharmacotherapy is Q1 in Pharmacology (medical) (rank 18 of 278) and Q1 in Cardiology and Cardiovascular Medicine (rank 30 of 409), by CiteScore 2025.
European Heart Journal - Cardiovascular Pharmacotherapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 11, which places it in quartile Q1 at the 93rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.014, quartile Q1, with an H-index of 50.
The publisher lists an article processing charge of about US$4,501 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
European Heart Journal - Cardiovascular Pharmacotherapy is published by Oxford University Press. Its print ISSN is 2055-6837 and its online ISSN is 2055-6845.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
European Heart Journal - Cardiovascular Pharmacotherapy has an h-index of 60 and a 2-year mean of 5.01 citations per paper (OpenAlex). Its Scopus CiteScore is 11, quartile Q1. On 2-year citations it ranks #25 of 271 Scopus journals in Pharmacology (medical).
European Heart Journal - Cardiovascular Pharmacotherapy published 96 papers in 2025; its busiest recent year was 2020 with 147. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from Italy (22.9%), Sweden (13.2%) and China (9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.